Literature DB >> 17699211

Lessons learned from recent hypertension trials about kidney disease.

Nitin Khosla1, George Bakris.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 17699211     DOI： 10.2215/CJN.00840805

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  4 in total

Review 1.  Management of hypertension in chronic kidney disease.

Authors:  Pasquale Zamboli; Luca De Nicola; Roberto Minutolo; Valerio Bertino; Fausta Catapano; Giuseppe Conte
Journal:  Curr Hypertens Rep       Date:  2006-12       Impact factor: 5.369

2.  Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.

Authors:  Matsuhiko Hayashi; Shunya Uchida; Tetsuya Kawamura; Michio Kuwahara; Masaomi Nangaku; Yasuhiko Iino
Journal:  Clin Exp Nephrol       Date:  2015-02-14       Impact factor: 2.801

Review 3.  Losartan chemistry and its effects via AT1 mechanisms in the kidney.

Authors:  Feichao Xu; Caiping Mao; Yujuan Liu; Lei Wu; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 4.  Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review.

Authors:  Rui Li; Jing Xing; Xaojing Mu; Hui Wang; Lei Zhang; Yu Zhao; Yu Zhang
Journal:  Drug Des Devel Ther       Date:  2015-12-03       Impact factor: 4.162
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.